Publications
37
Citations
94
Est. group size
—
Recurring co-author estimate
Active years
16
Publishing since 2011
Sofa Sánchez conducts medical research spanning cancer treatment and human physiology. Much of the work focuses on prostate cancer and other urological cancers\u2014evaluating imaging markers, hormone and radiation therapies, and survival outcomes\u2014alongside physiological studies on how diet factors like salt and ketone supplementation affect blood pressure, immune cells, and metabolism.
Publication activity has grown notably in recent years, rising from about one paper per year around 2019-2021 to five or more per year from 2023 onward.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- High salt and ketone supplementation alter terminal effector T cell phenotypes in apparently healthy adults
Physiology · 2026
- 24-Hour Blood Pressure after Short-Term High Salt and Ketone Supplementation in Middle-Aged and Older Adults
Physiology · 2026
- Hydration mediates cross-sectional associations between acute kidney injury biomarkers and race in emerging adults
Physiology · 2026
- Influence of Salt and Ketone Supplementation on Unstimulated and Lipopolysaccharide-Stimulated Cytokine Concentrations in Apparently Healthy Adults
Physiology · 2026
- The influence of salt loading and ketone supplementation on the plasma metabolome in apparently healthy adults
Physiology · 2026
- Pilot Investigation on Markers of Bone Metabolism, Angiogenesis, and Neuroendocrine Activity as Potential Predictors of Survival of Metastatic Prostate Cancer Patients with Bone Metastases
International Journal of Molecular Sciences · 2025
- Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer
Cancers · 2025
- 4348 Integrating ADC and PSA as predictive factors of treatment response to androgen deprivation therapy and radiotherapy in prostate cancer
Radiotherapy and Oncology · 2025
- Integrating Apparent Diffusion Coefficient and Prostate-Specific Antigen as Prognostic Factors of Treatment Response to Androgen Deprivation Therapy and Radiotherapy in Prostate Cancer
Biomedicines · 2025
- Survival outcomes with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: Real-world data from second-line and maintenance treatment
European Urology Open Science · 2025
- First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO)
Blood · 2025
- Transcriptomic analysis of subarachnoid cysts of Taenia solium reveals mechanisms for uncontrolled proliferation and adaptations to the microenvironment
Scientific Reports · 2024
- Treatment Patterns and Survival Outcomes Before and After Access to Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma: A Single-Center Retrospective Study From 2004 to 2021
Clinical Genitourinary Cancer · 2024
- Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis
Clinical & Translational Oncology · 2024
- Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution
Clinical & Translational Oncology · 2024
- Physiology×8
- Journal of Clinical Oncology×4
- Clinical & Translational Oncology×2
- Hypertension×2
- Scientific Reports×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile